Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-030986
Filing Date
2021-08-02
Accepted
2021-08-02 16:30:40
Documents
2
Period of Report
2021-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2252
2 EX-24 DOCUMENT attachment1.htm EX-24 4559
  Complete submission text file 0000899243-21-030986.txt   8291
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O LANTHEUS HOLDINGS, INC. 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address
Sabens Andrea (Reporting) CIK: 0001876279 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36569 | Film No.: 211136414